Kyowa Kirin Co., Ltd.
184
7
14
148
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.4%
21 terminated/withdrawn out of 184 trials
87.6%
+1.1% vs industry average
30%
56 trials in Phase 3/4
17%
25 of 148 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (184)
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Role: lead
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Role: lead
X-linked Hypophosphatemia Disease Monitoring Program
Role: collaborator
A Study of KK2269 in Adult Participants With Solid Tumors
Role: lead
Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）
Role: collaborator
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Role: lead
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Role: collaborator
Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Role: lead
A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
Role: collaborator
A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation
Role: collaborator
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Role: lead
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Role: lead
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Role: lead
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Role: lead
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
Role: lead
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia
Role: lead
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)
Role: lead
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
Role: lead
A Study of KHK4827 in Patients With Systemic Sclerosis
Role: lead
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
Role: lead